Suarez-Almazor ME - Search Results

1

Arthritis risk with immune checkpoint inhibitor therapy for cancer.

Pundole X, Abdel-Wahab N, Suarez-Almazor ME. Pundole X, et al. Curr Opin Rheumatol. 2019 May;31(3):293-299. doi: 10.1097/BOR.0000000000000601. Curr Opin Rheumatol. 2019. PMID: 30870217 Review.

2

Evidence-based rheumatology practice.

Krishnan LL, Suarez-Almazor ME. Krishnan LL, et al. Curr Opin Rheumatol. 2005 Mar;17(2):117-23. doi: 10.1097/01.bor.0000154201.49338.f6. Curr Opin Rheumatol. 2005. PMID: 15711221 Review.

3

Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.

Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, O'Malley KJ, Janssen NM, Marcus DM, Tagore J, Suarez-Almazor ME. Garcia Popa-Lisseanu MG, et al. J Rheumatol. 2005 May;32(5):913-9. J Rheumatol. 2005. PMID: 15868630

4

Initiation of disease-modifying antirheumatic drug therapy in minority and disadvantaged patients with rheumatoid arthritis.

Suarez-Almazor ME, Berrios-Rivera JP, Cox V, Janssen NM, Marcus DM, Sessoms S. Suarez-Almazor ME, et al. J Rheumatol. 2007 Dec;34(12):2400-7. Epub 2007 Nov 1. J Rheumatol. 2007. PMID: 17985405

5

Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus.

Garcia-Gonzalez A, Richardson M, Garcia Popa-Lisseanu M, Cox V, Kallen MA, Janssen N, Ng B, Marcus DM, Reveille JD, Suarez-Almazor ME. Garcia-Gonzalez A, et al. Clin Rheumatol. 2008 Jul;27(7):883-9. doi: 10.1007/s10067-007-0816-6. Epub 2008 Jan 8. Clin Rheumatol. 2008. PMID: 18185905

6

New understanding and approaches to treatment in rheumatoid arthritis.

Tayar JH, Suarez-Almazor ME. Tayar JH, et al. Br Med Bull. 2010;94:201-14. doi: 10.1093/bmb/ldq007. Epub 2010 Mar 2. Br Med Bull. 2010. PMID: 20200013 Review.

7

A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis.

Pollono EN, Lopez-Olivo MA, Lopez JA, Suarez-Almazor ME. Pollono EN, et al. Clin Rheumatol. 2010 Sep;29(9):947-55. doi: 10.1007/s10067-010-1405-7. Epub 2010 Apr 10. Clin Rheumatol. 2010. PMID: 20383550 Review.

8

Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.

de Achaval S, Suarez-Almazor ME. de Achaval S, et al. Int J Clin Rheumtol. 2010 Jun 1;5(3):313-326. doi: 10.2217/ijr.10.15. Int J Clin Rheumtol. 2010. PMID: 20676388 Free PMC article.

9

Neoplastic and paraneoplastic synovitis.

Marengo MF, Suarez-Almazor ME, Lu H. Marengo MF, et al. Rheum Dis Clin North Am. 2011 Nov;37(4):551-72. doi: 10.1016/j.rdc.2011.09.008. Rheum Dis Clin North Am. 2011. PMID: 22075197 Review.

10

Performance of risk indices for identifying low bone mineral density and osteoporosis in Mexican Mestizo women with rheumatoid arthritis.

Gonzalez-Lopez L, Gamez-Nava JI, Vega-Lopez A, Rodriguez-Jimenez NA, Gonzalez-Montoya N, Aguilar-Chavez E, Alcaraz-Lopez MF, Rocha-Muñoz AD, Castro-Lizano N, Morales-Romero J, Salazar-Paramo M, Suarez-Almazor ME. Gonzalez-Lopez L, et al. J Rheumatol. 2012 Feb;39(2):247-53. doi: 10.3899/jrheum.110467. Epub 2011 Dec 15. J Rheumatol. 2012. PMID: 22174197

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

427 results

Search Page